Logan Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-280
Closed -$4.89K 553
2025
Q1
$4.89K Hold
280
﹤0.01% 460
2024
Q4
$4.85K Hold
280
﹤0.01% 431
2024
Q3
$5.21K Hold
280
﹤0.01% 425
2024
Q2
$4.31K Hold
280
﹤0.01% 413
2024
Q1
$4.14K Hold
280
﹤0.01% 421
2023
Q4
$4K Hold
280
﹤0.01% 439
2023
Q3
$3.9K Hold
280
﹤0.01% 431
2023
Q2
$3.3K Hold
280
﹤0.01% 433
2023
Q1
$3.22K Hold
280
﹤0.01% 449
2022
Q4
$3.48K Hold
280
﹤0.01% 473
2022
Q3
$4K Hold
280
﹤0.01% 457
2022
Q2
$4K Hold
280
﹤0.01% 482
2022
Q1
$4K Hold
280
﹤0.01% 490
2021
Q4
$4K Hold
280
﹤0.01% 508
2021
Q3
$4K Hold
280
﹤0.01% 495
2021
Q2
$5K Sell
280
-224
-44% -$3.99K ﹤0.01% 478
2021
Q1
$9K Buy
+504
New +$8.86K ﹤0.01% 435

Other funds holding SBRA

Logan Capital Management's SBRA Position: Q2 2025 in Review

Logan Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 280 shares — an estimated $4.89K sold.

Logan Capital Management first reported a position in SBRA in Q1 2021 and held it in 17 quarters. The position peaked at $9K in Q1 2021. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Logan Capital Management reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Logan Capital Management sold 280 Sabra Healthcare REIT shares in Q2 2025, an estimated $4.89K.
  • Logan Capital Management first reported a position in Sabra Healthcare REIT in Q1 2021 and held it in 17 quarters.
  • Logan Capital Management's Sabra Healthcare REIT position peaked at $9K in Q1 2021.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Logan Capital Management's 13F filing for Q2 2025, filed 1 Aug 2025.